RDDS 2024 — Welcome and Opening Keynote: Shifting the Paradigm to Push Past Limits

June 7, 2024

Advocates are dramatically altering the landscape of rare research and reducing the timeline for rare disease therapy development. What is it that allows some organizations to move faster, be more nimble, use resources effectively and blaze new paths? Is there a matrix that can help you determine what will work for you?

Charlene Son Rigby
CEO, Global Genes

Tania Simoncelli
Vice President, Science in Society, Chan Zuckerburg Initiative